Company Filing History:
3 out of 932 
1 out of 4,455 
1 out of 220 
Years Active: 1987-2004
Title: Lynda M. Sanders: Pioneering Innovations in Intranasal Administration
Introduction
Lynda M. Sanders, an inventive force based in Palo Alto, California, has made significant contributions to the field of pharmaceutical sciences. With a portfolio of five patents, her work focuses primarily on the intranasal administration of polypeptides, showcasing her innovative approach to drug delivery systems.
Latest Patents
Lynda's most recent patents reflect her expertise in the field of nasal administration. These include:
1. **Intranasal administration of polypeptides in powdered form** - This patent involves pharmaceutical compositions of biologically active polypeptides in powder form, designed for nasal administration. The formulation comprises a therapeutically effective amount of a biologically active polypeptide and a water-soluble polysaccharide.
2. **Intranasal administration of LHRH polypeptides in powdered form** - Similar to her previous patent, this invention focuses on pharmaceutical compositions specifically tailored for the nasal administration of LHRH polypeptides, also utilizing a blend of biologically active polypeptides and water-soluble polysaccharides.
Career Highlights
Throughout her career, Lynda has worked with reputable companies, contributing her knowledge and skills to leading pharmaceutical organizations. Notably, she has been associated with Syntex Inc. and Pfizer Corporation, where she played a pivotal role in developing innovative drug delivery systems that have the potential to revolutionize therapeutic approaches.
Collaborations
Collaboration has been a vital aspect of Lynda's journey as an inventor. She has worked closely with esteemed colleagues, such as Brian H. Vickery and Eric J. Benjamin. These partnerships have further enriched her research and development activities, leading to groundbreaking advancements in her field.
Conclusion
Lynda M. Sanders stands out as a remarkable inventor in the pharmaceutical industry, particularly in the domain of intranasal administration. Her latest patents demonstrate her commitment to innovation and improving therapeutic outcomes. As research continues to evolve, Lynda's contributions will undoubtedly inspire future generations of inventors and researchers in the pursuit of enhanced drug delivery methodologies.